The findings suggest telenursing between in-person visits may help reduce distress related to symptoms in patients who have lung cancer.
Telenursing (TN) is associated with lower symptom distress compared with a lack of TN support in adults with lung cancer, according to new findings from a review and meta-analysis published in Japan Journal of Nursing Science.
Despite recent advances in lung cancer diagnosis and treatment, it remains the leading cause of cancer deaths worldwide and carries a fairly low 5-year survival rate. Considering the significant toxicity associated with lung cancer treatment, improving quality of life (QOL) for patients with lung cancer is an important goal.
One potential strategy to improve patient QOL between clinic or home care visits is providing additional support via TN. In general, TN is remote nursing care using information and communication technology (ICT) and telecommunication, as well as potentially telemonitoring (TM) of physical and mental health metrics, such as vital signs. This allows for more timely evaluations and increased communication between in-person visits, which may help improve patient QOL.
“TM in combination with home nursing has been used to capture physical changes in people with lung cancer that could not be detected by nurse visits alone and has been useful in alleviating suffering,” the authors wrote. Their review and analysis aimed to provide clarity on the QOL benefits of TN during lung cancer treatment.
Five reports on 4 studies were included in the review, and 3 of the studies were included in the meta-analysis. All of the studies were randomized controlled trials that included 2 arms for intervention and control groups. A total of 508 patients were included in the studies, and the majority of these patients had stage III-IV cancer. Providers taking part in TN interventions, which ranged in frequency from biweekly to twice a week in the studies, included nurses, clinicians, oncologists, oncology fellows, physicians, and physician assistants.
TM via patient-reported outcome (PRO) submission to health care providers was one type of intervention in the 3 studies that were analyzed. After patients submitted PRO symptoms by phone or software application, any responses that met predefined symptom thresholds generated an automated email to health care providers. Initial responses were typically handled by nurses, who could then contact the participant for further symptom assessment. Nursing professionals would provide clinical care when appropriate, counsel and educate patients, schedule visits, and contact oncologists when necessary to address a patient’s symptoms and concerns.
Another type of intervention was a health education program (EP) in the form of a website to inform patients of typical symptoms and management strategies. Question-and-answer opportunities were provided and monitored by a nurse and physician. The contents of the EP overall were revised periodically. Notably, only one study reported routine monitoring of vital signs and other typical measurements, which are often included in TM for patients with noncancer chronic diseases.
The meta-analysis focused on QOL and cancer-related symptoms as main outcomes. The pooled data showed that at 3 months of participation, there was no evidence of an effect on overall QOL between patients participating in TN vs the control groups. However, a pooled analysis of 2 of the studies with sufficient data found that TN led to lower distress related to cancer symptoms in patients who were included in TN.
“It is of noteworthy significance that health care providers can approach adults with lung cancer on a more regular basis using ICT between scheduled clinic visits to monitor and educate them about their symptoms,” the authors wrote.
Providing additional opportunities for education and assessments can help facilitate better treatment, and the use of PROs can help identify symptoms that may otherwise be missed by providers. Discussing symptoms with a provider remotely may also reduce the number of unplanned clinic or hospital visits if the distress surrounding those symptoms is alleviated by TN visits.
Notably, the data pool for the meta-analysis was small and a GRADE analysis of the data quality showed a serious risk of imprecision, bias, and inconsistency in the data. Further research is needed to provide more definitive data on the effects of TN for patients with lung cancer, but the findings of the meta-analysis suggest there is some benefit to remote monitoring in lung cancer care.
Reference
Harada T, Shibuya Y, Kamei T. Effectiveness of telenursing for people with lung cancer at home: a systematic review and meta-analysis. Jpn J Nurs Sci. Published online October 20, 2022. doi:10.1111/jjns.12516
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
2 Commerce Drive
Cranbury, NJ 08512